electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates

分组1 - electroCore, Inc. reported a quarterly loss of $0.35 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.32, but an improvement from a loss of $0.38 per share a year ago, resulting in an earnings surprise of -9.38% [1] - The company posted revenues of $7.38 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 0.83%, and showing an increase from $6.14 million in the same quarter last year [2] - electroCore has surpassed consensus revenue estimates two times over the last four quarters, while it has only exceeded consensus EPS estimates once during the same period [2] 分组2 - The stock has underperformed significantly, losing about 57.7% since the beginning of the year, compared to a 7.1% gain in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -$0.27 on revenues of $7.81 million, and for the current fiscal year, it is -$1.19 on revenues of $30.72 million [7] - The Zacks Industry Rank for Medical - Drugs is currently in the top 34% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]